Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Lancet (London, England)
|
March 1, 1997
How should we proceed with disease-modifying treatments for multiple sclerosis?
P B Andersson, E Waubant, D E Goodkin
Revue Neurologique
|
June 15, 1999
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]
E Waubant, R Sloan, P B Andersson, et al.
Advances in Neurology
|
January 1, 1993
Macrophage responses to central and peripheral nerve injury
V H Perry, M C Brown, P B Andersson
Neurology
|
September 17, 1999
A pilot study of MRI activity before and during interferon beta-1a therapy
E Waubant, D E Goodkin, R Sloan, et al.
Archives of Neurology
|
September 17, 1999
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability
P B Andersson, E Waubant, L Gee, et al.
Neurology
|
January 15, 2000
Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies
P B Andersson, E Yuen, K Parko, et al.
Neuroscience
|
October 1, 1993
Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier
D M Reid, V H Perry, P B Andersson, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
September 14, 2000
Antibodies to Chlamydia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur Hospital
S K Tregoning, R C Ballard, P B Andersson, et al.
Endocrinology
|
April 1, 1989
Gonadal steroid modulation of signal transduction and luteinizing hormone release in cultured chicken pituitary cells
J A King, J S Davidson, A E Mehl, et al.
Neurology
|
October 26, 1999
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
E Waubant, D E Goodkin, L Gee, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Lancet (London, England)
|
March 1, 1997
How should we proceed with disease-modifying treatments for multiple sclerosis?
P B Andersson, E Waubant, D E Goodkin
Revue Neurologique
|
June 15, 1999
[Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis]
E Waubant, R Sloan, P B Andersson, et al.
Advances in Neurology
|
January 1, 1993
Macrophage responses to central and peripheral nerve injury
V H Perry, M C Brown, P B Andersson
Neurology
|
September 17, 1999
A pilot study of MRI activity before and during interferon beta-1a therapy
E Waubant, D E Goodkin, R Sloan, et al.
Archives of Neurology
|
September 17, 1999
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability
P B Andersson, E Waubant, L Gee, et al.
Neurology
|
January 15, 2000
Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies
P B Andersson, E Yuen, K Parko, et al.
Neuroscience
|
October 1, 1993
Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier
D M Reid, V H Perry, P B Andersson, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
September 14, 2000
Antibodies to Chlamydia trachomatis in patients presenting with ectopic pregnancy at Groote Schuur Hospital
S K Tregoning, R C Ballard, P B Andersson, et al.
Endocrinology
|
April 1, 1989
Gonadal steroid modulation of signal transduction and luteinizing hormone release in cultured chicken pituitary cells
J A King, J S Davidson, A E Mehl, et al.
Neurology
|
October 26, 1999
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
E Waubant, D E Goodkin, L Gee, et al.
Page
of 3